CLASS II Drug recall · Reported 6 Aug 2014 · FDA Enforcement Report

Losartan Potassium and Hydrochlorothiazide Tablets recalled

Jubilant Cadista Pharmaceuticals is recalling Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg per, distributed nationwide in the US. The recall was initiated on 11 Jul 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #14P0292, Exp 04/2016
NDC59746-337, 59746-338, 59746-339
UPC0359746338107, 0359746337100, 0359746339104
Quantity recalled9,358 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1500-2014
FDA event ID
68776
Recalling firm
Jubilant Cadista Pharmaceuticals, Salisbury, MD
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.
Classification
Class II
Status
Terminated
Recall initiated
11 Jul 2014
FDA classified
31 Jul 2014
Reported
6 Aug 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Foreign Material

Timeline

11 Jul 2014Recall initiated by company
31 Jul 2014Classified by FDA+20 days
6 Aug 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.

Which lots are affected?

Lot #14P0292, Exp 04/2016

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Jubilant Cadista Pharmaceuticals

All 31

Other Losartan recalls

All 97
ReportedClassRecallCompanyReasonWhere
DrugCLASS IILosartan Potassium and Hydrochlorothiazide Tablets recalledLosartan Potassium And HydrochlorothiazideMacleods Pharma USAForeign MaterialNationwide
DrugCLASS IILosartan Potassium Tablets, USP, 25 mg recalled by Strides PharmaLosartan PotassiumStrides PharmaForeign MaterialNationwide
DrugCLASS IILosartan potassium & Hydrochlorothiazide Tablets 100 mg/25 recalledLosartan Potassium And HydrochlorothiazideMacleods Pharma UsaPotency & AssayNationwide
DrugCLASS IILosartan Potassium Tablets, USP 25 mg recalled by PD-Rx PharmaceuticalsLosartan PotassiumPD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILosartan Potassium Tablets, USP 100 mg recalled by PD-Rx PharmaceuticalsLosartan PotassiumPD-Rx PharmaceuticalsPotency & AssayNationwide